Skip to content
Search

Latest Stories

PDA Ability Network launches ‘Standing up for Sitting Down’ campaign against disability discrimination

PDA Ability Network launches ‘Standing up for Sitting Down’ campaign against disability discrimination

The association urges employers to make appropriate reasonable adjustments for employees with disabilities and health conditions

The Pharmacists' Defence Association (PDA) Ability Network on Thursday launched a campaign to combat disability discrimination in the workplace.


Called ‘Standing Up for Sitting Down’, the campaign was created after the network members shared their difficulties in persuading their employer to allow them to sit down at work despite having physical health problems.

Encompassing both mental and physical disabilities, the campaign highlights the level of discrimination and abuse that PDA members with disabilities face at work.

One member shared, “I needed to sit down and check as my feet hurt a lot. But the manager would not allow this and took the chair away.” Another recounted, “I was called a lazy cow by the dispenser for sitting to check prescriptions.”

The PDA Ability Network is encouraging its members to exercise their rights by calling on employers to make appropriate reasonable adjustments. Additionally, the network is aiming to create a zero-tolerance culture towards discrimination.

A recent PDA Ability Network survey on disability discrimination revealed that 52 per cent of respondents reported experiencing discrimination at work, and 40 per cent said they felt excluded from the workforce, underemployed, or unemployed due to their disability.

“It is unacceptable that highly skilled pharmacists are unable to work due to disability discrimination,” the association noted.

The ‘Standing up for Sitting Down’ campaign outlines three key actions:

  • Ensuring members understand and assert their rights under the Equality Act as pharmacists, trainee pharmacists, or students with disabilities.
  • Urging employers to make and regularly review reasonable adjustments for employees with disabilities and health conditions.
  • Encouraging employers to collaborate with PDA representatives and active members to create a compassionate culture of dignity in the workplace where there is zero tolerance for discrimination.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less